NDATOPICALCREAM
Approved
Oct 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 1h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MENTAX (butenafine hydrochloride) is a topical antifungal cream approved in 1996 for treatment of dermatophyte infections and other fungal skin conditions. It works by inhibiting fungal cell membrane synthesis, making it effective for localized cutaneous mycoses. The product is administered as a cream applied directly to affected skin areas.
$0.01BPart D
LOE ApproachingAs a mature product approaching loss of exclusivity with minimal Part D spending, the brand team is likely small and focused on defending market share against generic erosion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS
Started Jan 2019
42 enrolled
Tinea Pedis
Career Relevance
Working on MENTAX offers limited career advancement due to its LOE-approaching status and minimal linked job openings; however, roles in commercial defense and generic transition management provide valuable experience in portfolio lifecycle management. This is a stable maintenance assignment rather than a high-growth opportunity.
Brand Manager
Worked on MENTAX at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.